Ticker >

Cian Healthcare share price

Cian Healthcare Ltd.

BSE: 542678 SECTOR: Pharmaceuticals & Drugs  11k   16   1

21.47
+0.30 (1.42%)
BSE: 26 Apr 04:01 PM

Price Summary

Today's High

₹ 21.52

Today's Low

₹ 20.55

52 Week High

₹ 41.1

52 Week Low

₹ 16.05

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

53.67 Cr.

Enterprise Value

95.1 Cr.

No. of Shares

2.5 Cr.

P/E

49.84

P/B

1.04

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  20.55

CASH

1.13 Cr.

DEBT

42.56 Cr.

Promoter Holding

27.1 %

EPS (TTM)

₹  0.43

Sales Growth

5.4%

ROE

1.98 %

ROCE

6.16%

Profit Growth

147.32 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cian Healthcare Ltd.

celesta norwich jmsims gelios cardiac care trans I vac cianstar cinex blue care

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year5.4%
3 Year5.8%
5 Year0.5%

Profit Growth

1 Year147.32%
3 Year156.49%
5 Year-23.1%

ROE%

1 Year1.98%
3 Year-0.49%
5 Year0.41%

ROCE %

1 Year6.16%
3 Year5.27%
5 Year6.46%

Debt/Equity

0.8286

Price to Cash Flow

24.94

Interest Cover Ratio

1.25055312043415

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 27.1 47.77
Sep 2023 49.62 18.83
Mar 2023 51.85 18.02
Dec 2022 66.26 34.11
Sep 2022 66.26 34.11
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.338306525889427.
  • The company has an efficient Cash Conversion Cycle of -14.554122941733 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 8.66357279312414.

 Limitations

  • The company has shown a poor revenue growth of 5.80122312252411% for the Past 3 years.
  • Company has a poor ROE of -0.491396918076067% over the past 3 years.
  • Promoter pledging has increased from 18.8349302586323% to 47.77% in 1 quarter.
  • The company is trading at a high PE of 49.84.
  • Promoter stake has been decreased from 49.62% to 27.1%.
  • Promoter pledging is high as 47.77%.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 62.44 57.05 72.38 64.1 67.56
Total Expenditure 54.58 49.34 62.99 59.07 58.5
Operating Profit 7.86 7.71 9.39 5.04 9.06
Other Income 1.02 0.79 0.33 0.47 0.54
Interest 5.52 5.9 6.4 5.25 4.79
Depreciation 2.39 2.45 2.45 2.57 3.64
Exceptional Items -0.04 -0.07 -0.2 -0.07 0.03
Profit Before Tax 0.94 0.07 0.67 -2.38 1.2
Tax 0.29 0.15 0.34 -0.1 0.12
Net Profit 0.66 -0.07 0.33 -2.28 1.08
Adjusted EPS (Rs.) 0.38 -0.03 0.14 -0.91 0.43

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 17.14 23.36 23.36 25 25
Total Reserves 4.56 36.19 36.51 35.35 36.43
Borrowings 22.86 24.49 18.37 19.99 12.9
Other N/C liabilities 1.87 2.95 3.34 2.58 8.32
Current liabilities 45.58 47.7 53.05 56.87 57.99
Total Liabilities 92.02 134.69 134.63 139.78 140.63
Assets
Net Block 23.48 20.78 18.73 32.82 29.42
Capital WIP 6.37 24.8 25.71 13 13.89
Intangible WIP 0 0 0 0 0
Investments 0 7.09 7.09 7.09 7.09
Loans & Advances 6.7 22.55 19.95 15.19 11.95
Other N/C Assets 0 7.92 5.48 2.9 10.05
Current Assets 55.47 51.55 57.67 68.79 68.24
Total Assets 92.02 134.69 134.63 139.78 140.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.94 0.07 0.33 -2.28 1.08
Adjustment 7.07 7.9 8.1 7.1 7.6
Changes in Assets & Liabilities 1.21 -17.22 -2.96 0.69 -6.53
Tax Paid 0 0 0 0 0
Operating Cash Flow 9.21 -9.24 5.46 5.51 2.15
Investing Cash Flow -4.69 -25.16 -1.2 -3.85 -1.08
Financing Cash Flow -2.78 35.09 -5.07 -2.65 -1.17
Net Cash Flow 1.74 0.69 -0.81 -0.99 -0.1

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Dec 2022% Mar 2023% Sep 2023% Mar 2024%
promoters 66.26 66.26 51.85 49.62 27.10
kavita suraj zanwar 9.60 9.60 9.60 9.06 1.21
pankaj shriniwas zanwar 16.80 16.80 16.80 16.80 13.76
shakuntala shriniwas zanw... 2.40 2.40 2.40 2.40 2.04
suraj shriniwas zanwar 37.45 37.45 23.04 21.36 10.09
PARTICULARS Sep 2022% Dec 2022% Mar 2023% Sep 2023% Mar 2024%
investors 33.74 33.74 48.15 50.38 72.90
archana mandhani 1.16 1.16 1.16 1.16 1.16
dayal tours and travels i... - - - - 2.00
girija amit sharma 1.82 1.82 1.82 1.82 1.82
kaushal sunil tambe - - - - 1.50
koushal govindprasad shar... 1.60 1.60 1.60 1.60 1.60
prakashchandra rathi - - 20.00 15.90 15.42
ravi ashok kothari - - - - 2.52
sahi trading private limi... - - - 4.38 4.02
shweta sachin bhansali - - - - 1.05
sonali dilip sanklecha - - - - 4.00
indiacredit risk manageme... 8.35 8.19 2.55 - -
prakash chandra rathi 6.75 6.75 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Cian Healthcare informs about receipt of adjudication order of penalties 19 Mar 2024, 4:55PM Cian Healthcare informs about disclosure6 Dec 2023, 5:06PM Cian Healthcare enters into agreement with HLL Lifecare6 Dec 2023, 12:48PM Cian Healthcare informs about disclosure 9 Nov 2023, 2:23PM Cian Healthcare informs about disclosure4 Nov 2023, 12:16PM Cian Healthcare informs about disclosure 12 Oct 2023, 3:12PM Cian Healthcare informs about appointment of additional director12 Oct 2023, 3:04PM Cian Healthcare inks merchant export agreement with Tamil Pharma11 Oct 2023, 5:13PM Cian Healthcare informs about disclosure11 Oct 2023, 4:42PM Cian Healthcare enters into agreement with CHI Pharmaceuticals, Nigeria22 Aug 2023, 12:59PM Cian Healthcare gets nod to dispose off 100% stake in Dr. Smiths Biotech10 Jun 2023, 4:27PM Cian Healthcare submits revised audited financial results2 Jun 2023, 4:01PM Cian Healthcare informs about board meeting24 May 2023, 12:38PM Cian Healthcare informs about outcome of board meeting27 Sep 2022, 3:18PM Cian Healthcare informs about annual report5 Sep 2022, 5:08PM Cian Healthcare informs about appointment of director 26 Aug 2022, 12:57PM Cian Healthcare informs about compliance certificate22 Apr 2022, 1:19PM Cian Healthcare informs about compliance certificate 22 Apr 2022, 1:01PM Cian Healthcare informs about disclosure27 Dec 2021, 1:03PM Cian Healthcare informs about board meeting18 Dec 2021, 11:34AM Cian Healthcare informs about EGM proceedings25 Nov 2021, 4:47PM Cian Healthcare informs about outcome of EGM meeting 24 Nov 2021, 1:40PM Cian Healthcare informs about newspaper publication23 Nov 2021, 1:41PM Cian Healthcare informs outcome of about board meeting22 Nov 2021, 10:43AM Cian Healthcare informs about EGM 1 Nov 2021, 11:07AM Cian Healthcare informs about revised notice of EGM23 Oct 2021, 10:21AM Cian Healthcare informs about resignation of director16 Oct 2021, 3:22PM Cian Healthcare informs about outcome of EGM12 Oct 2021, 12:52PM Cian Healthcare informs about certificate6 Oct 2021, 9:55AM Cian Healthcare informs about AGM30 Sep 2021, 4:50PM Cian Healthcare informs about EGM notice20 Sep 2021, 11:32AM Cian Healthcare informs about outcome of board meeting18 Sep 2021, 1:09PM

Cian Healthcare Stock Price Analysis and Quick Research Report. Is Cian Healthcare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Cian Healthcare and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Cian Healthcare cash from the operating activity was Rs 2.1518 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Cian Healthcare has a Debt to Equity ratio of 0.8286 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Cian Healthcare , the EPS growth was 147.314662273476 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Cian Healthcare has OPM of 13.416408506053 % which is a bad sign for profitability.
     
  • ROE: Cian Healthcare have a poor ROE of 1.97911344245904 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Cian Healthcare is Rs 21.47. One can use valuation calculators of ticker to know if Cian Healthcare share price is undervalued or overvalued.
Last Updated on:
Brief about Cian Healthcare
X